Carlyle Taps Banks for $400M India IPO of RCM Unit

Carlyle Group Inc. has engaged JM Financial Ltd. and Goldman Sachs Group Inc. to assist with a potential initial public offering (IPO) of its India-based healthcare revenue cycle management (RCM) business. This move signals Carlyle's intention to list the RCM unit on the stock market, with the IPO potentially valued at approximately $400 million. The specific timeline for the IPO has not yet been disclosed, but the hiring of these investment banks indicates that the process is moving forward.

The RCM business operates within the healthcare sector in India, focusing on managing patient billing, insurance claims, and other financial aspects of healthcare providers. The potential IPO aims to raise capital for further expansion and development of the business, as well as to provide liquidity for Carlyle's investment in the unit. This listing would represent a significant exit for Carlyle from this particular asset.

Sources familiar with the matter, who requested anonymity due to the confidential nature of the discussions, revealed the involvement of JM Financial and Goldman Sachs. The decision to pursue an IPO rather than a direct sale to another company suggests Carlyle believes the public markets will offer a more favorable valuation for the RCM business. The Indian IPO market has seen a resurgence in recent years, making it an attractive venue for companies seeking to raise capital.

Carlyle Group, a global investment firm, has been actively managing its portfolio of investments. The potential IPO of its Indian RCM business is part of its broader strategy to optimize its holdings and generate returns for its investors. The success of this IPO could pave the way for further investment opportunities in the Indian healthcare and technology sectors.